Second-line treatment for primary central nervous system lymphoma
Author Information
Author(s): Reni M, Ferreri A J M, Villa E
Primary Institution: Department of Radiochemotherapy, San Raffaele H Scientific Institute
Hypothesis
Does salvage therapy improve outcomes for patients with primary central nervous system lymphoma who experience treatment failure?
Conclusion
Salvage therapy significantly improves outcomes and possibly quality of life for patients with primary central nervous system lymphoma after first-line treatment failure.
Supporting Evidence
- Failure after first-line treatment was reported in 35–60% of patients.
- Median time to death was 14 months for patients who underwent salvage therapy.
- Relapsed patients had a longer time to death than those with progressive disease.
Takeaway
If someone with brain cancer doesn't get better after their first treatment, a second treatment can help them live longer and feel better.
Methodology
The study analyzed prognostic factors and the efficacy of salvage therapy based on data from 355 cases of first-line treatment.
Limitations
Different treatments were used, making it hard to determine the best treatment schedule.
Participant Demographics
Patients included were immunocompetent with primary central nervous system lymphoma who experienced treatment failure.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.00001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website